STAT

Opinion: Big data often yields small returns. Here’s how to fix that

In the rush to data mining in health care, poor choices of data and poor data science can diminish health rather than improve it.
Data mining in health care has some parallels with the Gold Rush of the 19th century.

“Mining” is a popular shorthand expression for how we uncover important insights buried in big data. So when I read recently that a record 1,040 students signed up for Stanford University’s CS229 Machine Learning course by the first day of class, I thought of the 19th-century Gold Rush to the same part of the country.

Consider the parallels beyond geography: Something valuable and hidden is suddenly found, and appears to be everywhere. Early adopters use simple methods to get rich. As word spreads, people with scant knowledge make huge personal investments as the reward seems so attainable. The 1840s equivalent of CS229 was San Francisco, which grew 78 times larger in five

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks